Clinical Outcomes caused by COVİD-19 in patients with Sickle Cell Disease in the Hatay Province of Turkey

Basit Öğe Kaydı
dc.contributor.authorKaçmaz, Murat
dc.contributor.authorİlhan, Gül
dc.contributor.authorOktay, Gönül
dc.date.accessioned2024-09-19T16:26:47Z
dc.date.available2024-09-19T16:26:47Z
dc.date.issued2023
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractObjective: The COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) can be mortal particularly due to respiratory system involvement and coagulopathy. On the other hand, respiratory system involvement and coagulopathy are among the major causes of mortality in sickle cell patients as well. There are conflicting results in the literature on the mortality rates caused by COVID-19 in sickle cell patients. For this reason, we aimed to show the course of COVID-19 in sickle cell patients. Material and Method: Our study was created from the data of 21 sickle cell patients in the adult age group who were infected with SARS-COV-2. The laboratory and imaging results of these patients were reviewed. Result: The median age of the patients in the study was 34 years and 57% of the patients were male. 72% (n:15) of the patients needed to be admitted to the hospital and three of them died. The CRP level in individuals who died was found to be statistically significantly higher (HR, 1.02; 95% CI, 1.01-1.03; p=0.049). Conclusion: In this patient group, the requirement for hospitalization has increased significantly and mortality rates have increased in comparison to the general population. Patients with a high CRP value should be monitored closely since they can have a fatal outcome.en_US
dc.identifier.doi10.53394/akd.980857
dc.identifier.endpage50en_US
dc.identifier.issn1300-1779
dc.identifier.issn2687-2781
dc.identifier.issue1en_US
dc.identifier.startpage44en_US
dc.identifier.trdizinid1151972en_US
dc.identifier.urihttps://doi.org/10.53394/akd.980857
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1151972
dc.identifier.urihttps://hdl.handle.net/20.500.12483/16340
dc.identifier.volume9en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofAkdeniz Tıp Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSickle cell dieasesen_US
dc.subjectscaen_US
dc.subjectcovid-19en_US
dc.titleClinical Outcomes caused by COVİD-19 in patients with Sickle Cell Disease in the Hatay Province of Turkeyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
16340.pdf
Boyut:
930.39 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu